Politics Jan 17 Ex-Rep. Collins gets over 2 years in insider trading case By Larry Neumeister, Associated Press
World Oct 01 Watch 7:00 News Wrap: Iraqi forces fire on protesters in Baghdad In our news wrap Tuesday, violence broke out in Baghdad as security forces fired on crowds protesting corruption and a lack of jobs. Officials said one person was killed and some 200 hurt. Also, a mass march in Hong Kong…
Politics Oct 01 Ex-Rep. Chris Collins pleads guilty in insider trading case After his plea, Collins expressed regret and said he had failed his constituents. By Tom Hays, Associated Press
World Sep 30 Watch 5:35 News Wrap: Kremlin says it must O.K. Putin-Trump transcript before release In our Monday news wrap, the Kremlin declared that U.S. officials need Russian consent before releasing transcripts of President Trump's phone calls with Russian President Vladimir Putin. Democratic lawmakers are pressing for their release. Also, two front-runners in Afghanistan's presidential…
Politics Sep 30 GOP Rep. Collins resigns ahead of expected guilty plea Collins is facing charges that he illegally leaked confidential information about a biopharmaceutical company to his son. By Tom Hays, Associated Press
Sep 17 GOP Rep. Chris Collins, indicted for insider trading, to stay on ballot in New York By Associated Press The surprise decision by Collins, who pleaded not guilty to insider trading charges in August, throws the race for the western New York seat further into turmoil. Continue reading
Aug 11 Facing indictment, Rep. Chris Collins ends re-election bid By Karen Matthews, Associated Press Republican U.S. Rep. Chris Collins says he will no longer run for re-election after being charged with insider trading. Continue reading
Aug 08 Watch 5:15 News Wrap: Collins indicted for insider trading, criminal cover-up In our news wrap Wednesday, New York Republican Rep. Chris Collins and his son are under indictment for alleged insider trading. Prosecutors say his son dumped stock in a pharmaceutical company after Collins alerted him that an experimental drug had… Continue watching
Jan 13 Tom Price, Trump’s HHS nominee, got a sweetheart deal from a foreign biotech firm By Jay Hancock and Rachel Bluth, Kaiser Health News When Australian biotech firm Innate Immunotherapeutics needed to raise money last summer, it offered a sweetheart deal to “sophisticated U.S. investors.” One of them was Rep. Tom Price. Continue reading